Clinical Trials Browser

Terminated × Microarray Analysis × Plasma cell × Clear all

NCT00567229 2015-11-20

Lenalidomide and Rituximab in Treating Patients With Recurrent and/or Refractory Multiple Myeloma

Phase 2 Terminated

3 enrolled 6 charts

Multiple Myeloma, Neoplasms, Plasma Cell